Hosted on MSN3h
For Your Patients: What Is Multiple Myeloma?
Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...
emjreviews.com6h
High-Risk Genetic Markers Predict Poor Outcomes in Multiple Myeloma
Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.
Medpage Today on MSN12h
The Basics of Multiple Myeloma
In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...
Regeneron Pharmaceuticals, Inc.: Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...
Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...
Rolling Out6d
A rare cancer, modified cells, and the future they promised
A couple facing a terminal multiple myeloma diagnosis finds renewed hope through innovative immunotherapy, transforming blood ...
Finanznachrichten6d
Sanofi: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment ... predict and generally beyond the control of Sanofi, that could cause actual ...
Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma
Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed ...
This Couple Talks About Navigating a Rare Blood Cancer as a Team
From uncertainty to hope for the future, they offer advice on getting through some of the toughest years of their lives ...